More pediatric deaths have happened in 2025 than any other year since 2009, reflecting a drop in childhood vaccination rates.

The HHS will require all new vaccines to undergo placebo-controlled trials, likely slowing down approvals and decreasing access.

Daily oral immunotherapy with peanut protein significantly increased tolerance in the majority of adults with allergy.

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).

The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.

Physical exercise reduced psychological, cardiological, and neurological adverse effects in people with cancer.

The biosimilar SYSA1902 is similar to reference ustekinumab for both efficacy and safety measures among patients with plaque psoriasis.

Phototherapy with topical antioxidants is the most effective combination for vitiligo, followed by corticosteroids and calcineurin inhibitors.

The majority of patients with advanced melanoma who stop treatment with immune checkpoint inhibitor therapies remain relapse-free.

Three children have died in the most recent outbreak of measles. This article reviews the symptoms and treatment of measles.

Power outages longer than four hours, especially large-scale ones, increased the risk for pediatric carbon monoxide poisoning.